Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 5/2019

01-05-2019 | Letter to the Editor

Atypical bortezomib-induced neutrophilic dermatosis

Authors: Alain Lescoat, Alain Dupuy, Nicolas Belhomme, Nathalie Stock, Martine Sebillot, Olivier Decaux, Patrick Jégo, Catherine Droitcourt

Published in: Annals of Hematology | Issue 5/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Reyes-Habito CM, Roh EK (2014) Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: part II. Targeted therapy. J Am Acad Dermatol 71(2):217
2.
Obeid KM, Ferrera R, Sharma M (2012) A cutaneous lesion induced by a subcutaneous administration of bortezomib clinical practice points. Clin Lymphoma Myeloma Leuk 12:284–286CrossRef
3.
Von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31(4):535–556CrossRef
4.
Kolb-Mäurer A, Kneitz H, Goebeler M (2013) Sweet-like syndrome induced by bortezomib. J Dtsch Dermatol Ges 11(12):1200–1202
5.
Van Regenmortel N, Van de Voorde K, De Raeve H et al (2005) Bortezomib-induced Sweet’s syndrome. Haematologica 90(12 Suppl):ECR43
6.
Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW (2009) Bortezomib-induced histiocytoid Sweet syndrome. J Am Acad Dermatol 60(3):496–497CrossRef
7.
Knoops L, Jacquemain A, Tennsted D et al (2005) Bortezomib- induced Sweet syndrome. Br J Haematol 131(2):142CrossRef
8.
Thuillier D, Lenglet A, Chaby G, Royer R, Vaida I, Viseux V, Dadban A, Billet A, Christophe O, Chatelain D, Marolleau JP, Lok C, Damaj G (2009) Bortezomib-induced eruption: sweet syndrome? Two case reports. Ann Dermatol Venereol 136(5):427–430CrossRef
9.
Walker D, Cohen P (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923CrossRef
10.
Zobniw CM, Saad SA, Kostoff D, Barthel BG (2014) Bortezomib-induced Sweet’s syndrome confirmed by rechallenge. Pharmacotherapy 34(4):e18–e21CrossRef
Metadata
Title
Atypical bortezomib-induced neutrophilic dermatosis
Authors
Alain Lescoat
Alain Dupuy
Nicolas Belhomme
Nathalie Stock
Martine Sebillot
Olivier Decaux
Patrick Jégo
Catherine Droitcourt
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3519-y

Other articles of this Issue 5/2019

Annals of Hematology 5/2019 Go to the issue

Letter to the Editor

Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis

Original Article

Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome

Original Article

Different prognostic effects of core-binding factor positive AML with Korean AML registry data

Original Article

Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults

Letter to the Editor

Extracavitary primary effusion lymphoma (PEL) presenting as bilateral adrenal gland involvement in an HIV-positive patient

Original Article

Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits